This paper reports on the synthesis of a panel of small molecules with arylamides and arylsulfonamides groups and their biological activity in inhibiting nucleotide exchange on human Ras. The design of these molecules was guided by structure-activity data previously collected on similar compounds. Aim of this work is the validation of the hypothesis that a phenyl hydroxylamine group linked to a second aromatic moiety generates a pharmacophore capable to interact with Ras and to inhibit its activation. In vitro experiments on purified human Ras clearly show that the presence of an aromatic hydroxylamine and a sulfonamide group in the same molecule is necessary to Ras binding and nucleotide exchange inhibition. The inhibitor potency is lower in molecules in which either the hydroxylamine has been replaced by other functional groups or the sulfonamide has been replaced by an amide. In this case both these moieties, the hydroxylamine and sulfonamide are absent, inactive compounds are obtained.

Colombo, S., Palmioli, A., Airoldi, C., Tisi, R., Fantinato, S., Olivieri, S., et al. (2016). Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors. In B.S.P. Atta-ur-Rahman (a cura di), Advances in Cancer Drug Targets (pp. 245-264). Bentham Science Publishers [10.2174/97816810823321160301].

Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors

Colombo, S;Palmioli, A;Airoldi, C;Tisi, R;De Gioia, L;Martegani, E;Peri, F
2016

Abstract

This paper reports on the synthesis of a panel of small molecules with arylamides and arylsulfonamides groups and their biological activity in inhibiting nucleotide exchange on human Ras. The design of these molecules was guided by structure-activity data previously collected on similar compounds. Aim of this work is the validation of the hypothesis that a phenyl hydroxylamine group linked to a second aromatic moiety generates a pharmacophore capable to interact with Ras and to inhibit its activation. In vitro experiments on purified human Ras clearly show that the presence of an aromatic hydroxylamine and a sulfonamide group in the same molecule is necessary to Ras binding and nucleotide exchange inhibition. The inhibitor potency is lower in molecules in which either the hydroxylamine has been replaced by other functional groups or the sulfonamide has been replaced by an amide. In this case both these moieties, the hydroxylamine and sulfonamide are absent, inactive compounds are obtained.
No
Scientifica
Capitolo o saggio
Cancer, Ras proteins, inhibitors
English
Advances in Cancer Drug Targets
978-1-68108-234-9
Colombo, S., Palmioli, A., Airoldi, C., Tisi, R., Fantinato, S., Olivieri, S., et al. (2016). Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors. In B.S.P. Atta-ur-Rahman (a cura di), Advances in Cancer Drug Targets (pp. 245-264). Bentham Science Publishers [10.2174/97816810823321160301].
Colombo, S; Palmioli, A; Airoldi, C; Tisi, R; Fantinato, S; Olivieri, S; De Gioia, L; Martegani, E; Peri, F
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10281/220499
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact